Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | ILMN | ALNY | ||
| Company | Genmab A/S ADR | Illumina Inc | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.01 | 123.66 | 144.91 | ||
| High | 28.65 | 126.16 | 148.49 | ||
| Low | 28.01 | 123.35 | 143.50 | ||
| Last | 28.57 | 124.73 | 147.36 | ||
| Change | +0.42 | +2.45 | +4.05 | ||
| % Change | +1.49% | +2.00% | +2.83% | ||
| Volume | 593,100 | 908,800 | 439,800 | ||
| 20-Day Average Volume | 411,470 | 1,493,890 | 487,630 | ||
| Previous Close | 28.15 | 122.28 | 143.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.11 | 124.48 | 148.56 | ||
| 20-Day Raw Stochastic | 37.13% | 46.08% | 31.01% | ||
| 20-Day Relative Strength | 45.92% | 46.44% | 44.96% | ||
| Weighted Alpha | -28.18 | -34.18 | -30.36 | ||
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 8% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.38% since 04/22/24 | +3.73% since 04/22/24 | +1.08% since 04/22/24 | ||
| Low | 27.43 on 04/25/24 | 116.91 on 04/25/24 | 141.98 on 04/25/24 | ||
| High | 29.04 on 04/23/24 | 126.16 on 04/29/24 | 150.27 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -4.48% since 03/28/24 | -9.17% since 03/28/24 | -1.40% since 03/28/24 | ||
| Low | 27.43 on 04/25/24 | 115.73 on 04/18/24 | 141.98 on 04/25/24 | ||
| High | 30.50 on 04/04/24 | 138.53 on 04/01/24 | 159.34 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +0.99% since 01/29/24 | -14.99% since 01/29/24 | -18.57% since 01/29/24 | ||
| Low | 26.32 on 02/13/24 | 115.73 on 04/18/24 | 141.98 on 04/25/24 | ||
| High | 31.88 on 03/13/24 | 148.19 on 01/31/24 | 181.66 on 01/30/24 | ||
| 6-Month | |||||
| %Chg | +0.53% since 10/27/23 | +14.20% since 10/27/23 | -2.90% since 10/27/23 | ||
| Low | 26.32 on 02/13/24 | 89.00 on 11/10/23 | 141.98 on 04/25/24 | ||
| High | 32.89 on 11/17/23 | 148.19 on 01/31/24 | 199.38 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,613,624 | 19,473,702 | 18,049,320 | ||
| Shares Outstanding, K | 661,230 | 159,255 | 125,946 | ||
| Annual Sales | 2,392,030,000 | 4,504,000,000 | 1,828,290,000 | ||
| Annual Net Income | 631,910,000 | -1,161,000,000 | -440,240,000 | ||
| Last Quarter Sales | 674,810,000 | 1,122,000,000 | 439,720,000 | ||
| Last Quarter Net Income | 90,250,000 | -176,000,000 | -137,870,000 | ||
| 60-Month Beta | 0.99 | 1.19 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 02/14/24 | 0.14 on 02/08/24 | -1.10 on 02/15/24 | ||
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.27 | 139.14 | 0.00 | ||